If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Clinical Operations » Clinical Trial Management
Download FREE Excerpt
3 Info Graphics
14 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Biopharmaceutical companies support investigator-initiated trials (IITs) to explore novel opportunities to address unmet medical needs. However, as organizations increase the number of IIT trials, it is important for companies to properly vet each proposal and approve the ones that demonstrate scientific merit, and align with corporate objectives.
Best Practices, LLC undertook benchmarking research to provide a detailed roadmap for improving IIT management at biopharmaceutical companies, capturing critical metrics and insights on evaluating IIT proposals as well as improving performance, publication tactics and communication.
This study serves as a reference point for pharma leaders who oversee or work in investigator-initiated trials so that they can compare their IIT program aspects with industry peers.
Best Practices, LLC engaged 30 leaders from 23 bio-pharmaceutical and medical device companies through a benchmarking survey. Nearly 60% of participants are at the level of director or above.